These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 35202472)

  • 21. Enhanced predictive performance of the GRACE risk score by incorporating lipoprotein(a) for major adverse cardiac events in acute myocardial infarction patients undergoing PCI.
    Cheng X; Liu M; Wang Q; Xu Y; Liu R; Li X; Jiang H; Jiang S
    Int J Cardiol Cardiovasc Risk Prev; 2024 Sep; 22():200315. PubMed ID: 39157191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive Value of the Modified GRACE Scoring System for All-Cause Mortality in Patients with Acute Myocardial Infarction.
    Yan J; Deng CJ; Wang SF; Aimaitijiang M; Wu TT; Zheng YY; Xie X; Ma YT
    Rev Cardiovasc Med; 2023 Jun; 24(6):161. PubMed ID: 39077519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of the Risk Scores for Predicting In-Hospital Mortality in Patients with Acute Coronary Syndrome in a Chinese Cohort.
    Bai L; Li YM; Yang BS; Cheng YH; Zhang YK; Liao GZ; Ye YY; Chen XF; Chai H; Peng Y
    Rev Cardiovasc Med; 2023 Dec; 24(12):356. PubMed ID: 39077082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving Risk Stratification for Patients With Type 2 Myocardial Infarction.
    Taggart C; Monterrubio-Gómez K; Roos A; Boeddinghaus J; Kimenai DM; Kadesjo E; Bularga A; Wereski R; Ferry A; Lowry M; Anand A; Lee KK; Doudesis D; Manolopoulou I; Nestelberger T; Koechlin L; Lopez-Ayala P; Mueller C; Mills NL; Vallejos CA; Chapman AR
    J Am Coll Cardiol; 2023 Jan; 81(2):156-168. PubMed ID: 36631210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FOXO1 and ANGPT2 relative gene expression in non-ST-segment elevation myocardial infarction among patients with or without type 2 diabetes.
    Skowerski T; Nabrdalik K; Kwiendacz H; Pajak M; Ochała A; Mizia-Stec K; Gąsior Z; Gumprecht J
    Postepy Kardiol Interwencyjnej; 2021 Jun; 17(2):187-192. PubMed ID: 34400921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Risk factors for in-hospital mortality in patients with acute myocardial infarction during the COVID-19 outbreak].
    Solano-López J; Zamorano JL; Pardo Sanz A; Amat-Santos I; Sarnago F; Gutiérrez Ibañes E; Sanchis J; Rey Blas JR; Gómez-Hospital JA; Santos Martínez S; Maneiro-Melón NM; Mateos Gaitán R; González D'Gregorio J; Salido L; Mestre JL; Sanmartín M; Sánchez-Recalde Á
    Rev Esp Cardiol; 2020 Dec; 73(12):985-993. PubMed ID: 32963419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compelling Benefit of Soluble Suppression of Tumorigenicity-2 in Post-Myocardial Infarction Estimation of Risk: The Time Is Right for Its Routine Use in the Clinic.
    Díez J; Bayes-Genis A
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29054841
    [No Abstract]   [Full Text] [Related]  

  • 28. Timing of coronary angiography in patients with non-ST-elevation acute coronary syndrome: long-term clinical outcomes from the nationwide SWEDEHEART registry.
    Eggers KM; James SK; Jernberg T; Lindahl B
    EuroIntervention; 2022 Sep; 18(7):582-589. PubMed ID: 35352681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Prediction Model Based on Systemic Immune-Inflammatory Index Combined with Other Predictors for Major Adverse Cardiovascular Events in Acute Myocardial Infarction Patients.
    Li X; Yu C; Liu X; Chen Y; Wang Y; Liang H; Qiu S; Lei L; Xiu J
    J Inflamm Res; 2024; 17():1211-1225. PubMed ID: 38410422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triglyceride-glucose body mass index predicts prognosis in patients with ST-elevation myocardial infarction.
    Liu M; Pan J; Meng K; Wang Y; Sun X; Ma L; Yu X
    Sci Rep; 2024 Jan; 14(1):976. PubMed ID: 38200157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethnic Disparities in ST-Segment Elevation Myocardial Infarction Outcomes and Processes of Care in Patients With and Without Standard Modifiable Cardiovascular Risk Factors: A Nationwide Cohort Study.
    Weight N; Moledina S; Sun L; Kragholm K; Freeman P; Diaz-Arocutipa C; Dafaalla M; Gulati M; Mamas MA
    Angiology; 2024 Sep; 75(8):742-753. PubMed ID: 37306087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applications of artificial intelligence and machine learning in heart failure.
    Averbuch T; Sullivan K; Sauer A; Mamas MA; Voors AA; Gale CP; Metra M; Ravindra N; Van Spall HGC
    Eur Heart J Digit Health; 2022 Jun; 3(2):311-322. PubMed ID: 36713018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic ability using fatty liver and metabolic markers for metabolic-associated fatty liver disease stratified by metabolic/glycemic abnormalities.
    Okada A; Yamada G; Kimura T; Hagiwara Y; Yamaguchi S; Kurakawa KI; Nangaku M; Yamauchi T; Matsuyama Y; Kadowaki T
    J Diabetes Investig; 2023 Mar; 14(3):463-478. PubMed ID: 36566480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting 30-day mortality after ST elevation myocardial infarction: Machine learning- based random forest and its external validation using two independent nationwide datasets.
    Hadanny A; Shouval R; Wu J; Shlomo N; Unger R; Zahger D; Matetzky S; Goldenberg I; Beigel R; Gale C; Iakobishvili Z
    J Cardiol; 2021 Nov; 78(5):439-446. PubMed ID: 34154875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-hospital mortality analysis of Japanese patients with acute coronary syndrome using the Tokyo CCU Network database: Applicability of the GRACE risk score.
    Komiyama K; Nakamura M; Tanabe K; Niikura H; Fujimoto H; Oikawa K; Daida H; Yamamoto T; Nagao K; Takayama M;
    J Cardiol; 2018 Mar; 71(3):251-258. PubMed ID: 29102289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CAMI-NSTEMI Score　- China Acute Myocardial Infarction Registry-Derived Novel Tool to Predict In-Hospital Death in Non-ST Segment Elevation Myocardial Infarction Patients.
    Fu R; Song C; Yang J; Wang Y; Li B; Xu H; Gao X; Li W; Liu J; Dou K; Yang Y;
    Circ J; 2018 Jun; 82(7):1884-1891. PubMed ID: 29887577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk evaluation of new-onset atrial fibrillation complicating ST-segment elevation myocardial infarction: a comparison between GRACE and CHA
    Luo J; Dai L; Li J; Zhao J; Li Z; Qin X; Li H; Liu B; Wei Y
    Clin Interv Aging; 2018; 13():1099-1109. PubMed ID: 29922048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contemporary NSTEMI management: the role of the hospitalist.
    Pollack CV; Amin A; Wang T; Deitelzweig S; Cohen M; Slattery D; Fanikos J; DiLascia C; Tuder R; Kaatz S
    Hosp Pract (1995); 2020 Feb; 48(1):1-11. PubMed ID: 31815570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethnicity-dependent performance of the Global Registry of Acute Coronary Events risk score for prediction of non-ST-segment elevation myocardial infarction in-hospital mortality: nationwide cohort study.
    Moledina SM; Kontopantelis E; Wijeysundera HC; Banerjee S; Van Spall HGC; Gale CP; Shah BN; Mohamed MO; Weston C; Shoaib A; Mamas MA
    Eur Heart J; 2022 Jun; 43(24):2289-2299. PubMed ID: 35202472
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.